Article Details
Retrieved on: 2025-01-21 21:12:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Cell BioEngines joining CEPM to advance their stem-cell therapy platform, emphasizing regenerative medicine. It highlights collaboration with Icahn School and Rensselaer, integrating biotechnology, cell biology, and targeted therapies for medical innovation.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here